Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.05.06.723181

CardioSafe: Multi-task prediction of cardiac ion channel activity with reverse-leak audited benchmarking

Jovanovic, M.·Weidener, L. S.·Brkic, M.·Ulgac, E.·Meduri, A.
View original source ↗Export metadata ↓

Abstract

Drug-induced inhibition of the hERG potassium channel is the leading cause of cardiac safety-related drug attrition, but the Comprehensive in Vitro Proarrhythmia Assay (CiPA) framework requires activity data on multiple cardiac ion channels to assess proarrhythmic risk. We present CardioSafe, a three-branch multi-task neural network with cross-attention fusion that integrates chemical fingerprints, ChemBERTa embeddings, and predicted L1000 transcriptomic features to predict blocker status and potency for hERG, Nav1.5, and Cav1.2, with an exploratory IKs head. CardioSafe was trained on the largest publicly reported multi-channel cardiac ion channel dataset, combining ChEMBL 36 with the hERGCentral database (331127 hERG, 3160 Nav1.5, 1138 Cav1.2, and 115 IKs compounds), curated under a pharmacology-aware policy that retains censored measurements and inhibition-percentage votes. Under Tanimoto-similarity-controlled splits, CardioSafe outperforms the leading published comparators (CToxPred2 and CardioGenAI) on the data-rich hERG head; on the smaller Nav1.5 and Cav1.2 heads the standard evaluation is statistically inconclusive. A reverse-leak audit revealed that 22% of Nav1.5 and 21% of Cav1.2 test compounds were present in published comparators training data (92% as exact compound matches); after removing these contaminated compounds, CardioSafes lead on Nav1.5 and Cav1.2 also reaches statistical significance, demonstrating that prior cross-publication benchmarks for these channels were inflated by training-data overlap. Scientific contributionWe present the first multi-task neural network jointly predicting blocker activity for the three primary CiPA cardiac ion channels (hERG, Nav1.5, Cav1.2) within a single architecture. We introduce a reverse-leak audit methodology that reveals systematic test-set contamination in cross-publication cardiac safety benchmarks, establishing a stricter evaluation protocol. We provide the empirical test of predicted L1000 transcriptomic features as auxiliary input for cardiac ion channel prediction and document a well-characterized negative result. Graphical abstractCardioSafe encodes each query SMILES with three branches (chemical fingerprints + descriptors, pretrained ChemBERTa, and predicted L1000 transcriptomic signatures), fuses them via a cross-attention block with four learnable per-channel query tokens, and emits binary blocker calls plus pChEMBL regression for hERG, Nav1.5, Cav1.2, and (exploratory) IKs. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=59 SRC="FIGDIR/small/723181v1_ufig1.gif" ALT="Figure 1"> View larger version (13K): org.highwire.dtl.DTLVardef@1c0ba2aorg.highwire.dtl.DTLVardef@1fe3a0borg.highwire.dtl.DTLVardef@194de8aorg.highwire.dtl.DTLVardef@9e4f74_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jovanovic, M., Weidener, L. S., Brkic, M., Ulgac, E., Meduri, A.. 2026-05-12. CardioSafe: Multi-task prediction of cardiac ion channel activity with reverse-leak audited benchmarking. https://doi.org/10.64898/2026.05.06.723181

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗
bioRxiv2026

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗
bioRxiv2026

CryoMV: Structure-Prior-Guided Modeling and Real-Particle Validation of Continuous Conformational Transitions in Cryo-EM

Continuous protein conformations are essential for understanding fundamental biological processes and supporting drug discovery. Although cryo-EM can resolve individual states at high resolution, recovering continuous heterogeneity from 2D particle images remains challenging. High noise, motion blur, and limited structural priors make it difficult to accurately generate and validate high-resolution continuous conformations using raw particle data. Here, we introduce cryoMV, a framework that integrates structure-prior-guided modeling with real-particle validation for continuous conformational transitions. CryoMV uses reference density maps to establish structural anchors and motion priors, models candidate transition paths between selected conformations, and transfers the learned representation to raw 2D cryo-EM particle images. Each candidate conformation is subsequently evaluated using the estimated particle poses and contrast transfer functions. Supported conformations are reconstructed through raw particle back-projection and assessed using canonical half-maps and Fourier shell correlation. On EMPIAR-10516 and EMPIAR-10345, cryoMV achieves excellent performance in terms of robustness, verifiability, and reconstruction resolution. By incorporating structure-prior modeling and evidence from the raw particles, cryoMV offers an explicit mechanism for assessing whether generated conformations are supported by experimental data and provides a practical approach to reducing model-induced artifacts in continuous cryo-EM heterogeneity analysis.

bioinformatics↗